(Q51989890)

19 April 2018

title

Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. (English)

1 reference

19 April 2018

1 reference

Tamara Keith

1

1 reference

19 April 2018

Yuko Araki

2

1 reference

19 April 2018

Masaki Ohyagi

3

1 reference

19 April 2018

Maki Hasegawa

4

1 reference

19 April 2018

Kouhei Yamamoto

5

1 reference

19 April 2018

Morito Kurata

6

1 reference

19 April 2018

Yasunori Nakagawa

7

1 reference

19 April 2018

Kenshi Suzuki

8

1 reference

19 April 2018

Masanobu Kitagawa

9

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 May 2007

1 reference

19 April 2018

British Journal of Haematology

published in

1 reference

19 April 2018

volume

137

1 reference

19 April 2018

issue

3

1 reference

19 April 2018

page(s)

206-215

1 reference

19 April 2018

Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

The thin red line: angiogenesis in normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

A review on pro- and anti-angiogenic factors as targets of clinical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

"In vitro" evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Modulation of angiogenesis in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Angiogenesis and hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Pathobiology, classification, and diagnosis of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Angiogenic and lymphangiogenic molecules in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Angiogenesis in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Angiopoietins in tumours: the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

The dynamic roles of angiopoietins in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

Myelodysplastic syndrome is not merely "preleukemia"

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06539.X

10.1111/J.1365-2141.2007.06539.X

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018